Everpure, Inc. filings document corporate governance, shareholder voting matters, executive compensation, equity awards, and public-company reporting topics. The company's DEF 14A proxy statement includes disclosures tied to annual meeting matters, compensation tables, equity award values, vesting information, and governance oversight.
Everpure's regulatory record also supports disclosure around its operating company status, single reportable segment, capital and equity-compensation matters, and risk and governance subjects associated with a public technology company.
Everpure, Inc. (P) is the issuer for a planned resale of common stock under Rule 144 by THE EEC TRUST U/A DTD 02/08/2011. The trust has notified of an intended sale of 50,000 common shares, described as founders shares, with an indicated aggregate value of $4,853,000, through Morgan Stanley Smith Barney LLC. The notice also lists multiple recent Rule 10b5-1 plan sales of Everpure common stock over the prior three months by related trusts, including the EEC Trust, the RWC Trust, and the Colgrove Family Charitable Remainder Trust.
Everpure, Inc. (P) reported strong top-line and earnings growth for the quarter ended August 2, 2026, its second quarter of fiscal 2027. Total revenue rose to $1.19 billion, up 38% year over year, driven by 54% growth in product revenue and 20% growth in subscription services. Net income increased to $74.1 million from $47.1 million, and operating income improved sharply to $63.2 million from $4.9 million, even as gross margin eased slightly to 68%.
Subscription annualized recurring revenue reached $2.13 billion, up 20%, and remaining performance obligations were $4.1 billion, with 42% expected to convert to revenue within 12 months, underscoring visibility from Evergreen and other as-a-service offerings. The company closed the $125.9 million acquisition of 1touch, adding $19.5 million of intangibles and $101.2 million of goodwill, and secured a second top-five hyperscaler design win.
Cash generation, however, weakened: operating cash flow for the first half of fiscal 2027 fell to $43.8 million from $496.1 million, largely due to a large increase in prepaid expenses and other assets. Cash, cash equivalents and restricted cash declined to $396.4 million, while marketable securities stood at $622.2 million. Everpure also entered a long-term supply arrangement committing to approximately $1.1 billion of component purchases through calendar 2027 and has $262.9 million of lease payments on the books plus about $385.8 million of additional lease commitments not yet commenced.
Everpure, Inc. (P) reported strong results for the second quarter of fiscal 2027 ended August 2, 2026, with revenue of $1.19 billion, up 38% year-over-year. Product revenue was $686.8 million, up 54%, while subscription services revenue was $499.1 million, up 20%, supported by subscription ARR of $2.1 billion and RPO of $4.1 billion.
GAAP gross margin was 68.4% and non-GAAP gross margin 69.9%. GAAP operating income reached $63.2 million (5.3% margin), and non-GAAP operating income was $229.6 million (19.4% margin). Net income was $74.1 million, or $0.21 diluted EPS. The company ended the quarter with $1.0 billion in cash, cash equivalents, and marketable securities and repurchased $69 million of stock (0.9 million shares), but reported operating cash flow of $(136) million and free cash flow of $(237.6) million.
Everpure significantly raised its fiscal 2027 outlook, guiding revenue to $5.03–$5.07 billion (37–38% growth) and non-GAAP operating income to $940–$960 million (48–51% growth), and expects Q3 FY27 revenue of $1.325–$1.335 billion with non-GAAP operating income of $265–$275 million.
Everpure, Inc. director and Chief Visionary Officer John Colgrove reported gifts and sales of Class A Common Stock involving family trusts. On August 13–14, 2026, The Colgrove Family Charitable Remainder Trust received 329,630 shares by bona fide gift and sold 164,815 shares in open-market or private transactions at weighted-average prices generally between $112 and $118 per share, effected pursuant to a Rule 10b5-1 trading plan.
Issuer P has filed to sell 64,815 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on the NYSE, with an aggregate market value of $7,606,040.25 as of 08/14/2026. The issuer reports 332,404,932 shares of common stock outstanding.
The filing also lists recent Rule 10b5-1 plan sales by related trusts, including multiple transactions of 100,000 shares and 50,000 shares of common stock in June–August 2026, each with stated gross proceeds.
Everpure, Inc. director and Chief Visionary Officer John Colgrove reported a series of insider transactions in Class A Common Stock. On August 11–12, 2026, he made 400,000-share bona fide gifts to the Colgrove Family Charitable Remainder Trust and that trust executed open-market sales of 200,000 shares at weighted average prices ranging from $99.69 to $113.41 per share. The sales were carried out by the charitable remainder trust pursuant to a Rule 10b5-1 trading plan adopted on January 8, 2026. Additional shares are held indirectly through various family trusts, but post-transaction share balances are not specified here.
The filing reports a planned sale of 100,000 shares of common stock of company P through Morgan Stanley Smith Barney LLC Executive Financial Services, with an indicated aggregate market value of $11,140,000.00 and reference to 332,404,932 shares outstanding as of the planned sale date of August 13, 2026 on the NYSE.
It also lists prior Rule 10b5-1 plan sales over the past three months by several related trusts, including THE COLGROVE FAMILY CHARITABLE REMAINDER TRUST and the EEC and RWC trusts, with individual transactions such as 100,000 shares for $11,146,959.11 on August 12, 2026 and other sales in June and July 2026.
Everpure, Inc. CEO and director Giancarlo Charles H reported multiple open-market sales of Class A Common Stock on 2026-08-10, totaling 70,000 shares at weighted-average prices between the mid-$90s and just above $100 per share. The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on September 26, 2025. Following these sales, an indirect position of 731,414 shares is reported as held by the Giancarlo Family Trust.
An affiliate of the issuer with ticker P filed a notice of proposed sale of 100,000 shares of common stock. The shares are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services, with an indicated aggregate market value of $10,938,000.00 and stated shares outstanding of 332,404,932 as of the notice. The filing also lists multiple Rule 10b5-1 plan sales over the prior three months by several related trusts, each detailing shares sold and total sale proceeds.
Everpure, Inc. reported transactions by director and Chief Visionary Officer John Colgrove involving Class A common stock. On August 7 and 10, 2026, 270,370 shares were transferred as bona fide gifts to the Colgrove Family Charitable Remainder Trust, which then, along with related irrevocable trusts, sold 235,185 shares in multiple open-market transactions at weighted average prices around the reported per-share figures. The sale transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on January 8, 2026, and many shares were held and traded indirectly by family trusts rather than by Colgrove personally.